PHLDA3 Is an Important Downstream Mediator of p53 in Squamous Cell Carcinogenesis
- 1 April 2022
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (4) , 1040-1049.e8
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (20F20414)
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Agency for Medical Research and Development
- Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care
- Life Science Foundation of Japan
- Okinaka Memorial Institute for Medical Research
This publication has 37 references indexed in Scilit:
- Defining the origins of Ras/p53-mediated squamous cell carcinomaProceedings of the National Academy of Sciences, 2011
- Identifying the cellular origin of squamous skin tumorsProceedings of the National Academy of Sciences, 2011
- p53 Research: The Past Thirty Years and the Next Thirty YearsCold Spring Harbor Perspectives in Biology, 2010
- Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applicationsNature Protocols, 2009
- PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of AktCell, 2009
- Akt Activation Synergizes with Trp53 Loss in Oral Epithelium to Produce a Novel Mouse Model for Head and Neck Squamous Cell CarcinomaCancer Research, 2009
- p53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosisOncogene, 2008
- Dissecting functional roles of p53 N‐terminal transactivation domains by microarray expression analysisCancer Science, 2006
- Enamelin ( Enam ) is essential for amelogenesis: ENU-induced mouse mutants as models for different clinical subtypes of human amelogenesis imperfecta (AI)Human Molecular Genetics, 2005
- Reprimo, a New Candidate Mediator of the p53-mediated Cell Cycle Arrest at the G2 PhaseJournal of Biological Chemistry, 2000